Quick Answer
Apyx Medical Corp reported Diluted EPS of $0.54 per share (loss) for fiscal year 2023.
Apyx Medical Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$0.54 | +19.4% |
| 2022 | -$0.67 | -52.3% |
| 2021 | -$0.44 | -25.7% |
| 2020 | -$0.35 | +39.7% |
| 2019 | -$0.58 | -131.7% |
| 2018 | $1.83 | +1176.5% |
| 2017 | -$0.17 | -13.3% |
| 2016 | -$0.15 | -162.5% |
| 2015 | $0.24 | +123.3% |
| 2014 | -$1.03 | -157.5% |
| 2013 | -$0.40 | -1433.3% |
| 2012 | $0.03 | +200.0% |
| 2011 | $0.01 | +111.1% |
| 2010 | -$0.09 | -400.0% |
| 2009 | $0.03 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | -$0.19 | -533.3% | +13.6% |
| March 31, 2024 | -$0.22 | -120.0% | -69.2% |
| September 30, 2023 | -$0.13 | +23.5% | -333.3% |
| June 30, 2023 | -$0.03 | +81.2% | +70.0% |
| March 31, 2023 | -$0.10 | +41.2% | +41.2% |
| September 30, 2022 | -$0.17 | -41.7% | -6.3% |
| June 30, 2022 | -$0.16 | -33.3% | +5.9% |
| March 31, 2022 | -$0.17 | -21.4% | -41.7% |
- Apyx Medical Corp showed an increase of +19.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2023 period, Apyx Medical Corp’s diluted eps has declined by 1900.0% (from $0.03 per share to $0.54 per share (loss)).
- The most recent figure is from Apyx Medical Corp’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 21, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: